Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
J Cardiothorac Vasc Anesth. 2023 Sep;37(9):1700-1706. doi: 10.1053/j.jvca.2023.04.035. Epub 2023 Apr 30.
This study aimed to evaluate whether a measure of subjective cognitive decline (SCD), the Patient-Reported Outcomes Measurement Information System (PROMIS) Applied Cognition-Abilities questionnaire, was associated with postoperative delirium. It was hypothesized that delirium during the surgical hospitalization would be associated with a decrease in subjective cognition up to 6 months after cardiac surgery.
This was a secondary analysis of data from the Minimizing Intensive Care Unit Neurological Dysfunction with Dexmedetomidine-induced Sleep randomized, placebo-controlled, parallel-arm superiority trial.
Data from patients recruited between March 2017 and February 2022 at a tertiary medical center in Boston, Massachusetts were analyzed in February 2023.
Data from 337 patients aged 60 years or older who underwent cardiac surgery with cardiopulmonary bypass were included.
Patients were assessed preoperatively and postoperatively at 30, 90, and 180 days using the subjective PROMIS Applied Cognition-Abilities and telephonic Montreal Cognitive Assessment.
Postoperative delirium occurred within 3 days in 39 participants (11.6%). After adjusting for baseline function, participants who developed postoperative delirium self-reported worse cognitive function (mean difference [MD] -2.64 [95% CI -5.25, -0.04]; p = 0.047) up to 180 days after surgery, as compared with nondelirious patients. This finding was consistent with those obtained from objective t-MoCA assessments (MD -0.77 [95% CI -1.49, -0.04]; p = 0.04).
In this cohort of older patients undergoing cardiac surgery, in-hospital delirium was associated with SCD up to 180 days after surgery. This finding suggested that measures of SCD may enable population-level insights into the burden of cognitive decline associated with postoperative delirium.
本研究旨在评估主观认知下降(SCD)的测量指标,即患者报告的结局测量信息系统(PROMIS)应用认知能力问卷,是否与术后谵妄有关。假设心脏手术后住院期间出现谵妄,将与术后 6 个月主观认知下降有关。
这是对来自麻萨诸塞州波士顿一家三级医疗中心的 Minimizing Intensive Care Unit Neurological Dysfunction with Dexmedetomidine-induced Sleep 随机、安慰剂对照、平行臂优效性试验数据的二次分析。
2023 年 2 月对 2017 年 3 月至 2022 年 2 月间招募的 337 名 60 岁或以上接受体外循环心脏手术的患者的数据进行了分析。
纳入 337 名接受体外循环心脏手术的 60 岁或以上患者。
患者在术前、术后 30、90 和 180 天分别接受主观 PROMIS 应用认知能力和电话式蒙特利尔认知评估。
39 名患者(11.6%)在术后 3 天内发生术后谵妄。在调整基线功能后,与无谵妄患者相比,发生术后谵妄的患者自我报告的认知功能更差(平均差异 [MD] -2.64 [95% CI -5.25, -0.04];p = 0.047),直至术后 180 天。这一发现与客观 t-MoCA 评估结果一致(MD -0.77 [95% CI -1.49, -0.04];p = 0.04)。
在这组接受心脏手术的老年患者中,住院期间谵妄与术后 180 天内的 SCD 有关。这一发现表明,SCD 测量方法可能使人群能够深入了解与术后谵妄相关的认知下降负担。